Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Hematologic Malignancy Reports
Published in: Current Hematologic Malignancy Reports 4/2016

01-08-2016 | Health Economics (N Khera, Section Editor)

Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant

Authors: Anna Barata, William A. Wood, Sung Won Choi, Heather S. L. Jim

Published in: Current Hematologic Malignancy Reports | Issue 4/2016

Login to get access

Abstract

Individuals diagnosed with hematologic malignancies experience significant unmet psychological, physical, informational, financial, and spiritual needs. The goal of the current review is to summarize and highlight recent research focused on these issues in the diagnosis and treatment periods and beyond. The review also describes the needs of adolescent and young adult (AYA) and pediatric patients. While a large body of research has reported on unmet needs among adult hematologic cancer patients, there is far less data regarding the challenges confronted by AYA and pediatric populations. Available data suggests that among all age groups, hematopoietic cell transplantation (HCT) is a risk factor for greater unmet needs. Recommendations for screening and evidence-based interventions to prevent or ameliorate unmet needs are provided. Future research is needed to develop additional evidence-based psychosocial interventions with a focus on hematologic cancer.
Literature
1.•
Boyes AW et al. Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy. Acta Oncol. 2015;54:507–14. This is a recent, large study of unmet needs among hematologic cancer patients.PubMedCrossRef
2.
Hall A et al. Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study. Support Care Cancer. 2014;22:2899–909.PubMedCrossRef
3.
Lobb EA et al. When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77:103–8.PubMedCrossRef
4.
Armes J et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9.PubMedCrossRef
5.
Jim HS et al. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer. 2016;122:1290–7.PubMedCrossRef
6.
Sarkar S et al. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:1217–22.PubMedCrossRef
7.
Hoodin F et al. Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2013;19:1493–7.PubMedCrossRef
8.
Hefner J et al. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. Bone Marrow Transplant. 2014;49:581–4.PubMedCrossRef
9.
El-Jawahri AR et al. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer. 2016;122:806–12.PubMedCrossRef
10.
Phillips KM et al. Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer. 2013;21:1097–103.PubMedCrossRef
11.
Gheihman G et al. Depression and hopelessness in patients with acute leukemia: the psychological impact of an acute and life-threatening disorder. Psychooncology. 2015. doi:10.​1002/​pon.​3940.PubMed
12.
Zimmermann C et al. Symptom burden and supportive care in patients with acute leukemia. Leuk Res. 2013;37:731–6.PubMedCrossRef
13.
Pulgar A, Alcala A, Reyes Del Paso GA. Psychosocial predictors of quality of life in hematological cancer. Behav Med. 2015;41:1–8.PubMedCrossRef
14.
Horsboel TA et al. Are fatigue, depression and anxiety associated with labour market participation among patients diagnosed with haematological malignancies? A prospective study. Psychooncology. 2015;24:408–15.PubMedCrossRef
15.
Mumby PB et al. Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplant. 2012;47:556–61.PubMedCrossRef
16.
Prieto JM et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907–17.PubMedCrossRef
17.
Loberiza Jr FR et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2118–26.PubMedCrossRef
18.
Pillay B et al. Psychosocial factors predicting survival after allogeneic stem cell transplant. Support Care Cancer. 2014;22:2547–55.PubMedCrossRef
19.
20.
Wood WA et al. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013;19:450–9.PubMedCrossRef
21.
DuHamel KN et al. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol. 2010;28:3754–61.PubMedPubMedCentralCrossRef
22.
David N et al. Internet-based program for coping with cancer: a randomized controlled trial with hematologic cancer patients. Psychooncology. 2013;22:1064–72.PubMedCrossRef
23.
Applebaum AJ et al. Therapeutic alliance in telephone-administered cognitive-behavioral therapy for hematopoietic stem cell transplant survivors. J Consult Clin Psychol. 2012;80:811–6.PubMedPubMedCentralCrossRef
24.
Niederbacher S et al. Patients’ quality of life after allogeneic haematopoietic stem cell transplantation: mixed-methods study. Eur J Cancer Care (Engl). 2012;21:548–59.CrossRef
25.
Jim HS et al. Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life. Bone Marrow Transplant. 2014;49:299–303.PubMedCrossRef
26.
Korszun A et al. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors. Br J Haematol. 2014;164:790–803.PubMedCrossRef
27.
Kekale M, Peltoniemi M, Airaksinen M. Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment. Patient Prefer Adherence. 2015;9:1733–40.PubMedPubMedCentralCrossRef
28.
Grulke N, Albani C, Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant. 2012;47:473–82.PubMedCrossRef
29.
Braamse AM et al. Developing a risk prediction model for long-term physical and psychological functioning after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:549–56.PubMedCrossRef
30.
Phillips KM et al. A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:1350–7.PubMedPubMedCentralCrossRef
31.
Persoon S et al. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39:682–90.PubMedCrossRef
32.
van Haren IE et al. Physical exercise for patients undergoing hematopoietic stem cell transplantation: systematic review and meta-analyses of randomized controlled trials. Phys Ther. 2013;93:514–28.PubMedCrossRef
33.
Lawrence JA et al. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv. 2016;10:176–84.PubMedCrossRef
34.
Jean-Pierre P et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer. 2010;116:3513–20.PubMedPubMedCentralCrossRef
35.
36.
Rood JA et al. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences. Hematol Oncol. 2015;33:85–98.PubMedCrossRef
37.
Alexander SC et al. Information giving and receiving in hematological malignancy consultations. Psychooncology. 2012;21:297–306.PubMedCrossRef
38.
Montgomery C et al. Predicting psychological distress in patients with leukaemia and lymphoma. J Psychosom Res. 2003;54:289–92.PubMedCrossRef
39.
Efficace F et al. Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer. 2012;107:904–9.PubMedPubMedCentralCrossRef
40.
Maher M et al. A novel health information technology communication system to increase caregiver activation in the context of hospital-based pediatric hematopoietic cell transplantation: a pilot study. JMIR Res Protoc. 2015;4:e119.PubMedPubMedCentralCrossRef
41.
Horne B et al. Development and evaluation of a specifically designed website for haematopoietic stem cell transplant patients in Leeds. Eur J Cancer Care (Engl). 2015. doi:10.​1111/​ecc.​12352.
42.
Stienen JJ et al. Development and evaluation of an educational e-tool to help patients with non-Hodgkin’s lymphoma manage their personal care pathway. JMIR Res Protoc. 2015;4:e6.PubMedPubMedCentralCrossRef
43.
Syrjala KL et al. Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. J Cancer Surviv. 2011;5:292–304.PubMedPubMedCentralCrossRef
44.
Huntington SF et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2:e408–16.PubMedCrossRef
45.
Dusetzina SB et al. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32:306–11.PubMedCrossRef
46.
Khera N et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20:1375–81.PubMedCrossRef
47.
Kim W et al. Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient’s perspective. Bone Marrow Transplant. 2015;50:1259–61.PubMedCrossRef
48.
Stepanikova I et al. Exploring long-term cancer survivors’ experiences in the career and financial domains: Interviews with hematopoietic stem cell transplantation recipients. J Psychosoc Oncol. 2016;34:2–27.PubMedCrossRef
49.
Silla L et al. Patient socioeconomic status as a prognostic factor for allo-SCT. Bone Marrow Transplant. 2009;43:571–7.PubMedCrossRef
50.
Jim HS, Jacobsen PB. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J. 2008;14:414–9.PubMedCrossRef
51.
Tallman B et al. Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: a nine-year longitudinal study. Rehabil Psychol. 2010;55:204–10.PubMedCrossRef
52.
Leeson LA et al. Spirituality and the recovery of quality of life following hematopoietic stem cell transplantation. Health Psychol. 2015;34:920–8.PubMedCrossRef
53.
Prince P et al. Spiritual well-being in Hispanic and non-Hispanic survivors of allogeneic hematopoietic stem cell transplantation. J Psychosoc Oncol. 2015;33:635–54.PubMedPubMedCentralCrossRef
54.
Pereira DB et al. Spiritual absence and 1-year mortality after hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2010;16:1171–9.PubMedCrossRef
55.
Breitbart W et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol. 2015;33:749–54.PubMedPubMedCentralCrossRef
56.
Warner EL et al. Social well-being among adolescents and young adults with cancer: a systematic review. Cancer. 2016;122:1029–37.PubMedCrossRef
57.
Bellizzi KM et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118:5155–62.PubMedCrossRef
58.
Potosky AL, et al. Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst. 2014;106. doi: 10.​1093/​jnci/​dju300.
59.
Geue K et al. Gender-specific quality of life after cancer in young adulthood: a comparison with the general population. Qual Life Res. 2014;23:1377–86.PubMedCrossRef
60.
Prasad PK et al. Psychosocial and neurocognitive outcomes in adult survivors of adolescent and early young adult cancer: A report from the childhood cancer survivor Study. J Clin Oncol. 2015;33:2545–52.PubMedCrossRef
61.
Ness KK et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol. 2013;31:4496–503.PubMedPubMedCentralCrossRef
62.
Kent EE et al. Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer. J Adolesc Young Adult Oncol. 2013;2:44–52.PubMedPubMedCentralCrossRef
63.
64.
Guy Jr GP et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood). 2014;33:1024–31.CrossRef
65.
66.
Dyer G et al. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Br J Haematol. 2016;172:592–601.PubMedCrossRef
67.
Halliday LE, Boughton MA, Kerridge I. Liminal reproductive experiences after therapies for hematological malignancy. Qual Health Res. 2015;25:408–16.PubMedCrossRef
68.••
Joshi S et al. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014;49:477–84. This article provides important recommendations regarding fertility preservation for pediatric and AYA HCT recipients.PubMedPubMedCentralCrossRef
69.
Keegan TH et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6:239–50.PubMedPubMedCentralCrossRef
70.
Muffly LS et al. Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016;122:954–61.PubMedCrossRef
71.
Mattson MR, Demshar RK, Daly BJ. Quality of life of young adult survivors of hematologic malignancies. Cancer Nurs. 2013;36:E1–7.PubMedCrossRef
72.
Rabin C et al. Intervention format and delivery preferences among young adult cancer survivors. Int J Behav Med. 2013;20:304–10.PubMedCrossRef
73.••
Perales MA, et al. Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Curr Hematol Malig Rep. 2016. [Epub ahead of print]. This article provides useful social media resources for AYA cancer patients.
74.
Richter D et al. Psychosocial interventions for adolescents and young adult cancer patients: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2015;95:370–86.PubMedCrossRef
75.
Smith AW et al. Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future. Cancer. 2016;122:988–99.PubMedCrossRef
76.••
Nass SJ et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist. 2015;20:186–95. This article provides a summary of the current state of the science regarding the needs of AYA cancer patients.PubMedPubMedCentralCrossRef
77.
Badr H et al. Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer. J Cancer Surviv. 2013;7:523–34.PubMedCrossRef
78.
Compas BE et al. Children and adolescents coping with cancer: self- and parent reports of coping and anxiety/depression. Health Psychol. 2014;33:853–61.PubMedPubMedCentralCrossRef
79.
van der Geest IM et al. Emotional distress in 652 Dutch very long-term survivors of childhood cancer, using the hospital anxiety and depression scale (HADS). J Pediatr Hematol Oncol. 2013;35:525–9.PubMedCrossRef
80.
Chang G et al. Children’s psychological distress during pediatric HSCT: parent and child perspectives. Pediatr Blood Cancer. 2012;58:289–96.PubMedCrossRef
81.
Bingen K et al. A multimethod assessment of psychosocial functioning and late effects in survivors of childhood cancer and hematopoietic cell transplant. J Pediatr Hematol Oncol. 2012;34:22–8.PubMedCrossRef
82.
Cox CL, et al. The unmet emotional, care/support, and informational needs of adult survivors of pediatric malignancies. J Cancer Surviv. 2016. [Epub ahead of print].
83.
Zeltzer LK et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2396–404.PubMedPubMedCentralCrossRef
84.
Liu YM, et al. Quality of life after hematopoietic stem cell transplantation in pediatric survivors: comparison with healthy controls and risk factors. Cancer Nurs. 2016. [Epub ahead of print].
85.
86.
Seitz DC et al. Efficacy of an internet-based cognitive-behavioral intervention for long-term survivors of pediatric cancer: a pilot study. Support Care Cancer. 2014;22:2075–83.PubMedCrossRef
87.
van Dijk-Lokkart EM et al. Effects of a combined physical and psychosocial intervention program for childhood cancer patients on quality of life and psychosocial functioning: results of the QLIM randomized clinical trial. Psychooncology. 2015. doi:10.​1002/​pon.​4016.
88.
89.
Cox CL et al. Development of a comprehensive health-related needs assessment for adult survivors of childhood cancer. J Cancer Surviv. 2013;7:1–19.PubMedCrossRef
90.••
91.
Miller E, Jacob E, Hockenberry MJ. Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncol Nurs Forum. 2011;38:E382–93.PubMedCrossRef
92.
Mulrooney DA et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep. 2008;31:271–81.PubMedPubMedCentral
93.
Mulrooney DA et al. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. Cancer. 2008;112:2071–9.PubMedCrossRef
94.
Armenian SH et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118:1413–20.PubMedPubMedCentralCrossRef
95.
Clanton NR et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117:2559–68.PubMedPubMedCentralCrossRef
96.
Robinson KE et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer. 2010;54:585–90.PubMedPubMedCentral
97.
Willard VW et al. Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation. J Clin Oncol. 2014;32:3982–8.PubMedPubMedCentralCrossRef
98.
Nazari S et al. Emotional/Behavioral problems in children with acute lymphoblastic leukemia: a case-control study. Int J Hematol Oncol Stem Cell Res. 2014;8:14–20.PubMedPubMedCentral
99.
Schultz KA et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2007;25:3649–56.PubMedCrossRef
100.
Kirchhoff AC et al. Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Med Care. 2010;48:1015–25.PubMedPubMedCentralCrossRef
101.
Pelletier W, Bona K. Assessment of financial burden as a standard of care in pediatric oncology. Pediatr Blood Cancer. 2015;62 Suppl 5:S619–31.PubMedCrossRef
102.
Petridou ET et al. Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann Oncol. 2015;26:589–97.PubMedCrossRef
103.
Bona K et al. Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000–2010). Pediatr Blood Cancer. 2016;63:1012–8.PubMedCrossRef
104.
Kirchhoff AC et al. Supplemental security income and social security disability insurance coverage among long-term childhood cancer survivors. J Natl Cancer Inst. 2015;107:djv057.PubMedPubMedCentralCrossRef
105.
Bona K et al. Trajectory of material hardship and income poverty in families of children undergoing chemotherapy: a prospective cohort study. Pediatr Blood Cancer. 2016;63:105–11.PubMedCrossRef
106.
Donovan KA, Jacobsen PB. Progress in the implementation of NCCN guidelines for distress management by member institutions. J Natl Compr Canc Netw. 2013;11:223–6.PubMed
107.
Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract. 2014;10:e368–72.PubMedCrossRef
Metadata
Title
Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant
Authors
Anna Barata
William A. Wood
Sung Won Choi
Heather S. L. Jim
Publication date
01-08-2016
Publisher
Springer US
Published in
Current Hematologic Malignancy Reports / Issue 4/2016
Print ISSN: 1558-8211
Electronic ISSN: 1558-822X
DOI
https://doi.org/10.1007/s11899-016-0328-z

Other articles of this Issue 4/2016

Current Hematologic Malignancy Reports 4/2016 Go to the issue

CART and Immunotherapy (M Ruella, Section Editor)

Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies

Acute Lymphocytic Leukemias (K Ballen, Section Editor)

Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia

Health Economics (N Khera, Section Editor)

Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications

Health Economics (N Khera, Section Editor)

Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

Health Economics (N Khera, Section Editor)

Value Based Care and Patient-Centered Care: Divergent or Complementary?

Health Economics (N Khera, Section Editor)

Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits